July 23, 2014 1:45 PM ET

Pharmaceuticals

Company Overview of NitroMed, Inc.

Executive Profile

Kenneth M. Bate MBA

Non Executive Chairman and Member of Audit Committee, Cubist Pharmaceuticals Inc.
AgeTotal Calculated CompensationThis person is connected to 5 Board Members in 5 different organizations across 11 different industries.

See Board Relationships
63$402,000

Background

Mr. Kenneth M. Bate, also known as Ken, MBA serves as a Principal of JSB-Partners, LP. Mr. Bate serves as the President of Newport Acquisition Corp., a wholly owned subsidiary of NitroMed Inc. Mr. Bate served as the Chief Executive Officer and President of NitroMed Inc., since January 22 ,2007 and also its Interim Chief Financial Officer since April 11, 2008. Mr. Bate is an experienced biotechnology executive having led companies at various stages of development. Mr. ...

Corporate Headquarters

6000 Fairview Road
Charlotte, North Carolina 28210

United States

Phone: 704-941-2020
Fax: 704-941-2021

Board Members Memberships

Director
2003-Present
Non Executive Chairman and Member of Audit Committee
2005-N/A
Director, Member of Nominating and Governance Committee and Member of Audit Committee
2007-N/A
Chief Executive Officer, President, Interim Chief Financial Officer, Executive Director and President of Newport Acquisition Corp
2007-Present
Director, Chairman of Audit Committee and Member of Compensation Committee
2010-Present
Director, Chairman of Compensation Committee and Member of Audit Committee
2014-Present
Independent Director

Education

BA
Williams College
MBA
University of Pennsylvania - The Wharton School

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

Total Annual Cash Compensation$117,000
Total Calculated Compensation$402,000
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Rick E. Winningham Chairman, Chief Executive Officer, Member of Stock Option Committee and Member of Science & Technology Advisory Committee
Theravance Inc.
$986.9K
Carolyn J. Logan Chief Executive Officer, President and Director
Salix Pharmaceuticals Ltd.
$867.5K
Akira Kurokawa Chief Executive Officer, President and Director
Santen Pharmaceutical Co. Ltd.
--
Eduardo Javier Sanchiz Yrazu Chief Executive Officer, Member of Management Board, Chief Executive of Corporate Development & Finance, Executive Director and Member of Compliance Committee
Almirall, S.A.
--
Richard Martin Steeves BSc., Ph.D.Group Chief Executive Officer, Member of Senior Executive Board and Executive Director
Synergy Health plc
$823.0K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NitroMed, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.